New Staff Members Join Levine Cancer Institute
As Carolinas HealthCare System’s Levine Cancer Institute continues to build an elite cancer program, two more physicians join the growing team of nationally and internationally recognized cancer experts.
Joshua S. Hill, MD
Joshua S. Hill, MD, surgical oncologist, comes to the Institute after completing a fellowship in surgical oncology at the University of Texas, MD Anderson Cancer Center’s Department of Surgical Oncology in Houston.
Dr. Hill received his medical degree from The Ohio State University in Columbus and completed a residency in general surgery at the University of Massachusetts in Worcester. He has won several awards, including the Ferguson Award in Surgery, bestowed by The Ohio State University’s Department of Surgery and Resident Teacher of the Year Award from the University of Massachusetts.
Dr. Hill’s clinical interests focus on gastrointestinal, pancreatic and liver cancers. He will collaborate with Institute researchers on developing best practices for surgical and nonsurgical treatment of these cancers.
Steve B. Riggs, MD
Steve B. Riggs, MD, joins the Institute from Virginia, where he served as assistant professor and associate program director of the Department of Urology at Eastern Virginia School of Medicine (EVSM). Dr. Riggs has extensive clinical trials experience in various areas of urologic oncology, including bladder, kidney and prostate, having worked closely for several years with the famed prostate and bladder cancer surgeon Paul Schellhammer, MD.
Dr. Riggs received his medical degree from Medical University of South Carolina in Charleston. Following a surgery internship at Vanderbilt University Medical Center in Nashville, TN, he completed a urology residency at University of Mississippi Medical Center in Jackson and a fellowship in urologic oncology at the University of California Medical Center in Los Angeles. He has received several awards, including EVSM’s 2012 resident teaching award for the Department of Urology.
He has lectured at regional and international meetings on bladder, kidney and testicular cancer, as well as robot-assisted urologic surgery. Dr. Riggs is interested in urologic oncology, and in particular, how to reduce post-operative complications and improve patient experience.
Dr. Riggs is now seeing patients at McKay Urology in Charlotte, and will continue research efforts through the Institute’s clinical trials unit.